Keller, Douglas A.
Sanofi (United States)
2 papers on CoChatORCID 0000-0002-6186-2881
Most cited papers
- Verified
Current nonclinical testing paradigm enables safe entry to first-in-human clinical trials: the IQ consortium nonclinical to clinical translational database
Monticello, T. M., Jones, T. W., Dambach, D. M., Potter, D. M., Bolt, M. W., Liu, M., Keller, D. A., Hart, T. K., & Kadambi, V. J. (2017) · Toxicology and Applied Pharmacology
Animal testing and alternativesImmunotoxicology and immune responses
Cited by 186
- Verified
Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry
Baudy, A. R., Otieno, M. A., Hewitt, P., Gan, J., Roth, A., Keller, D., Sura, R., Van Vleet, T. R., & Proctor, W. R. (2020) · Lab on a Chip
3D Printing in Biomedical ResearchDrug-Induced Hepatotoxicity and Protection
Cited by 150
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free